Kyle Mikson
Stock Analyst at Canaccord Genuity
(3.69)
# 787
Out of 5,090 analysts
109
Total ratings
47.67%
Success rate
9.01%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Initiates: Hold | $28 | $28.86 | -2.98% | 1 | Dec 2, 2025 | |
| EXAS Exact Sciences | Downgrades: Hold | $85 → $105 | $101.06 | +3.90% | 10 | Nov 25, 2025 | |
| GRAL GRAIL | Maintains: Buy | $85 → $105 | $100.98 | +3.98% | 5 | Nov 17, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $16 → $19 | $17.77 | +6.92% | 9 | Nov 7, 2025 | |
| NTRA Natera | Maintains: Buy | $200 → $250 | $244.55 | +2.23% | 10 | Nov 7, 2025 | |
| VCYT Veracyte | Maintains: Hold | $40 → $43 | $44.61 | -3.61% | 2 | Nov 5, 2025 | |
| TEM Tempus AI | Maintains: Buy | $110 → $95 | $76.66 | +23.92% | 2 | Nov 5, 2025 | |
| ILMN Illumina | Maintains: Hold | $105 → $112 | $128.96 | -13.15% | 13 | Oct 31, 2025 | |
| GH Guardant Health | Maintains: Buy | $75 → $100 | $102.02 | -1.98% | 9 | Oct 30, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $155 → $160 | $158.96 | +0.65% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $150 → $165 | $164.98 | +0.01% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $15 | $7.20 | +108.33% | 5 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1 → $2 | $1.44 | +38.89% | 5 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $20 | $7.68 | +160.59% | 5 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 | $38.65 | -4.27% | 5 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $5 | $7.63 | -34.47% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $2.39 | +25.52% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.03 | +191.26% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.30 | +567.33% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.33 | +14,854.41% | 1 | Mar 30, 2021 |
Caris Life Sciences
Dec 2, 2025
Initiates: Hold
Price Target: $28
Current: $28.86
Upside: -2.98%
Exact Sciences
Nov 25, 2025
Downgrades: Hold
Price Target: $85 → $105
Current: $101.06
Upside: +3.90%
GRAIL
Nov 17, 2025
Maintains: Buy
Price Target: $85 → $105
Current: $100.98
Upside: +3.98%
10x Genomics
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $17.77
Upside: +6.92%
Natera
Nov 7, 2025
Maintains: Buy
Price Target: $200 → $250
Current: $244.55
Upside: +2.23%
Veracyte
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $44.61
Upside: -3.61%
Tempus AI
Nov 5, 2025
Maintains: Buy
Price Target: $110 → $95
Current: $76.66
Upside: +23.92%
Illumina
Oct 31, 2025
Maintains: Hold
Price Target: $105 → $112
Current: $128.96
Upside: -13.15%
Guardant Health
Oct 30, 2025
Maintains: Buy
Price Target: $75 → $100
Current: $102.02
Upside: -1.98%
GeneDx Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $155 → $160
Current: $158.96
Upside: +0.65%
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $164.98
Upside: +0.01%
Oct 27, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $7.20
Upside: +108.33%
Oct 27, 2025
Maintains: Hold
Price Target: $1 → $2
Current: $1.44
Upside: +38.89%
Sep 19, 2025
Maintains: Buy
Price Target: $30 → $20
Current: $7.68
Upside: +160.59%
Sep 9, 2025
Maintains: Buy
Price Target: $37
Current: $38.65
Upside: -4.27%
Aug 11, 2025
Downgrades: Hold
Price Target: $12 → $5
Current: $7.63
Upside: -34.47%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $2.39
Upside: +25.52%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.03
Upside: +191.26%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.30
Upside: +567.33%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.33
Upside: +14,854.41%